From a pancreatic cancer drug that doubles survival to blood tests that may spot tumours years before symptoms appear, ...

Dr Kimberly Ku hosted an episode of her podcast series "Val-YOU Based Care" live during ASCO 2026. Dr Kimberly Ku hosted an episode of her podcast series “Val-YOU Based Care” live during ASCO 2026.

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how ...

Scientists created an immunotherapy that tracks pancreatic cancer even after it spreads. The breakthrough treatment works in lab studies, though long-term safety in humans remains unknown.

Collaboration will apply Aignostics' AI-technology to PanCAN's multimodal pancreatic cancer dataset, with results made ...

The discovery of a drug called daraxonrasib, which a Florida doctor was part of, could have implications for extending ...

An expert highlights phase 3 trial data evaluating darovasertib as targeted therapy for advanced metastatic pancreatic ...

A new pancreatic cancer treatment may finally move the needle on what's proved to be an unforgiving disease. Fred Hutch ...

Dr. Jessica Gray, a family medicine physician, addresses findings from a Yale School of Medicine study concerning the link ...

Scientists at the Free University of Brussels (VUB) have taken a major step forward in pancreatic cancer research. By mapping ...

In this video from the National Kidney Foundation Spring Clinical Meetings, Paolo Cravedi, MD, PhD, discusses the ...

Chronic pancreatitis (CP) diminishes quality-of-life (QoL) across mobility, self-care, daily activities, mental health, and pain-not just abdominal discomfort-according to a new Mayo Clinic study ...